A. Tenzer

an Inhibitor of Protein Kinase C Target for the Anticancer and Radiosensitizing Agent PKC 412 ,-Kinase / Akt Survival Pathway Is a ′ The Phosphatidylinositide 3 Updated

D. Fabbro, S. Rocha, B. Hemmings, 2001 .

The phosphatidylinositide 3'-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C.

D. Fabbro, S. Rocha, B. Hemmings, 2001, Cancer research.

Novel radiosensitizers for locally advanced epithelial tumors: inhibition of the PI3K/Akt survival pathway in tumor cells and in tumor-associated endothelial cells as a novel treatment strategy?

O. Riesterer, M. Pruschy, S. Bodis, 2004, International journal of radiation oncology, biology, physics.

Potentiation of DNA-damage-induced cytotoxicity by G2 checkpoint abrogators.

M. Pruschy, A. Tenzer, 2003, Current medicinal chemistry. Anti-cancer agents.

LATEX: A peculiar biological component in airborne particles?

C. Monn, A. Tenzer, 2000 .

Key targets for the execution of radiation-induced tumor cell apoptosis: the role of p53 and caspases.

D. Fisher, S. Rocha, M. Pruschy, 2001, International journal of radiation oncology, biology, physics.